HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stephens, J. W. Articles by Ward, W. K. Search for Related Content PubMed PubMed Citation Articles by Stephens, J. W. Articles by Ward, W. K.

Ann Thorac Surg 1995;59:1259-1260
© 1995 The Society of Thoracic Surgeons

---

Articles

The effect of glucose priming solutions in diabetic patients undergoing coronary artery bypass grafting

^* Address reprint requests to Dr Ward, Portland Diabetes and Endocrinology Center, 1130 NW 22 Ave., Suite 400, Portland, OR 97210.

To assess the impact of glucose-containing priming solutions on plasma glucose level in diabetic patients during and after coronary artery bypass graft surgery, we studied 50 diabetic patients and 10 nondiabetic patients who underwent bypass graft surgery. Glucose-containing priming solutions profoundly elevated plasma glucose levels during and after bypass graft surgery. In diabetic patients who received glucose primes, intraoperative peak plasma glucose levels averaged 696 ± 48 mg/dl as compared with 341 ± 17 mg/dl in diabetic patients who received nonglucose primes (p < 0.001). Despite an insulin infusion, diabetic patients underwent a much slower decline in plasma glucose levels postoperatively over a 2-hour period than did nondiabetics (who did not receive an insulin infusion). We conclude that during and immediately after coronary artery bypass surgery in diabetic patients, it is desirable to avoid administration of glucose-containing priming solutions, since such solutions profoundly elevate plasma glucose levels.

This article has been cited by other articles:

				P. A Gustafson, D. L Zarro, D. A Palanzo, N. J Manley, R. M Montesano, M. Quinn, B.-A. Elmore, and J. M Castagna Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery Perfusion, March 1, 2002; 17(2): 141 - 144. [Abstract] [PDF]

				M. Chello, P. Mastroroberto, F. Cirillo, E. Bevacqua, A. Carrano, F. Perticone, and A. R. Marchese Neutrophil-endothelial cells modulation in diabetic patients undergoing coronary artery bypass grafting Eur J Cardiothorac Surg, October 1, 1998; 14(4): 373 - 379. [Abstract] [Full Text] [PDF]

				W. I. Brenner Insulin infusions and coronary artery bypass grafting Ann. Thorac. Surg., November 1, 1995; 60(5): 1460 - 1460. [PDF]